+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Micell Technologies Inc - Product Pipeline Analysis, 2018 Update

  • ID: 4455878
  • Company Profile
  • 33 pages
  • GlobalData
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 5

FEATURED COMPANIES

  • St. Jude Medical LLC
  • Unetixs Vascular Inc
  • Ventlab Corporation
  • MORE
Summary

Micell Technologies Inc (Micell) is a medical device company that develops drug delivery systems for the treatment of cardiovascular diseases. The company provides product such as MiStent sirolimus eluting absorbable polymer coronary stent system, a drug-eluting stent that is designed to optimize healing. It offers novel drug-coated balloon to deliver sirolimus to the artery wall at the site of a percutaneous transluminal angioplasty and stent implantation for peripheral and coronary indications. Micell provides a fluid-based technology platform to provide control over drug morphology and apply multiple therapeutic agents in single or multiple layers to achieve tailored therapeutics. The company also conducts clinical and pre-clinical trials. Micell is headquartered in Durham, North Carolina, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Micell Technologies Inc
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • St. Jude Medical LLC
  • Unetixs Vascular Inc
  • Ventlab Corporation
  • MORE
Micell Technologies Inc Company Overview
Micell Technologies Inc Company Snapshot
Micell Technologies Inc Pipeline Products and Ongoing Clinical Trials Overview
Micell Technologies Inc – Pipeline Analysis Overview
Micell Technologies Inc - Key Facts
Micell Technologies Inc - Major Products and Services
Micell Technologies Inc Pipeline Products by Development Stage
Micell Technologies Inc Ongoing Clinical Trials by Trial Status

Micell Technologies Inc Pipeline Products Overview
Bioresorbable Scaffold (BRS)
Bioresorbable Scaffold (BRS) Product Overview
Drug-Coated Balloon
Drug-Coated Balloon Product Overview
MiStent SES
MiStent SES Product Overview
MiStent SES Clinical Trial
Peripheral Drug-Eluting Stent
Peripheral Drug-Eluting Stent Product Overview

Micell Technologies Inc - Key Competitors

Micell Technologies Inc - Key Employees

Micell Technologies Inc - Locations And Subsidiaries
Head Office
Recent Developments

Micell Technologies Inc, Recent Developments
May 23, 2018: Positive Two-Year Data from MiStent DESSOLVE III Trial Presented at EuroPCR – Excellent Safety And Low Target Lesion Revascularization (TLR) Rates Persist
Mar 20, 2018: Micell Technologies Announces Expanded Patent Estate
Jan 09, 2018: Positive Five-Year Data Published for MiStent in EuroIntervention
Dec 06, 2017: The Lancet Publishes Twelve-Month Results for DESSOLVE III Highlighting MiStent Performance in All-Comers Randomized Trial; MiStent Achieved Primary Endpoint vs Xience
May 16, 2017: Micell Technologies Announces MiStent Achieved Primary Endpoint in All-Comers Randomized Clinical Trial Versus Xience
Nov 28, 2016: Micell Technologies Announces First Patient Enrolled In Landmark Registration Trial Of MiStent In Japan
Oct 31, 2016: Positive Five-Year Clinical Data from Micell Technologies' MiStent Presented at TCT 2016
Mar 22, 2016: Micell Technologies Completes Enrollment in OCT Study Designed to Evaluate Superior Performance of MiStent SES Compared to Xience
Feb 25, 2016: Micell Technologies Highlights Data From Published Propensity Analysis of MiStent SES and Market Standard Xience V Coronary Stent
Dec 09, 2015: Micell Technologies Announces Completion of Enrollment in MiStent Randomized Trial against Xience

Appendix
Methodology
About
Contact Us
Disclaimer

List of Tables
Micell Technologies Inc Pipeline Products and Ongoing Clinical Trials Overview
Micell Technologies Inc Pipeline Products by Equipment Type
Micell Technologies Inc Pipeline Products by Indication
Micell Technologies Inc Ongoing Clinical Trials by Trial Status
Micell Technologies Inc, Key Facts
Micell Technologies Inc, Major Products and Services
Micell Technologies Inc Number of Pipeline Products by Development Stage
Micell Technologies Inc Pipeline Products Summary by Development Stage
Micell Technologies Inc Ongoing Clinical Trials by Trial Status
Micell Technologies Inc Ongoing Clinical Trials Summary
Bioresorbable Scaffold (BRS) - Product Status
Bioresorbable Scaffold (BRS) - Product Description
Drug-Coated Balloon - Product Status
Drug-Coated Balloon - Product Description
MiStent SES - Product Status
MiStent SES - Product Description
MiStent SES - A Prospective, Single-blinded, Multi-center, Randomized, Controlled, Registered Clinical Trial on the Efficacy and Safety of Sirolimus-eluting Stent (MiStent System) in the Treatment of Patients with Coronary Heart Disease
MiStent SES - MiStent Sirolimus Eluting Absorbable Polymer Coronary Stent System (MiStent SES) Optical Coherence Tomography (OCT)
MiStent SES - Multicenter Randomized Study of the MiStent Sirolimus Eluting Absorbable Polymer Stent System (MiStent SES) for Revascularization of Coronary Arteries
MiStent SES - Multicenter Randomized Study of the Mistent Sirolimus Eluting Absorbable Polymer Stent System (MT005) for Revascularization of Coronary Arteries
Peripheral Drug-Eluting Stent - Product Status
Peripheral Drug-Eluting Stent - Product Description
Micell Technologies Inc, Key Employees
Glossary

List of Figures
Micell Technologies Inc Pipeline Products by Equipment Type
Micell Technologies Inc Pipeline Products by Development Stage
Micell Technologies Inc Ongoing Clinical Trials by Trial Status
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • Ventlab Corporation
  • Unetixs Vascular Inc
  • St. Jude Medical LLC
  • Abbott Cardiovascular Systems Inc
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Order Online - visit: https://www.researchandmarkets.com/reports/4455878
Adroll
adroll